Low-Dose Rate Brachytherapy With I-125 Seeds Has an Excellent 5-Year Outcome With Few Side Effects in Patients With Low-Risk Prostate Cancer

Acta Oncologica - United Kingdom
doi 10.1080/0284186x.2016.1175659

Related search